Rejuvenate Biomed
Science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€63—94m (Dealroom.co estimates Oct 2021.)
Company register number 0681.964.735
Diepenbeek Province of Belgian Limburg (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| EBITDA | (<1m) | (<1m) | <1m | <1m | <1m | - |
| Profit | (<1m) | (<1m) | (1.6m) | (1.8m) | (4.5m) | (5.1m) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | €460k | Grant | |
* | €3.2m | Series A | |
* | €15.7m | Series B | |
| Total Funding | €19.4m | ||
Recent News about Rejuvenate Biomed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.